- Home
- LVLU vs DYAI Comparison
LVLU vs DYAI Comparison
Compare LVLU & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVLU | DYAI |
|---|---|---|
| Founded | 1996 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8M | 32.5M |
| IPO Year | 2021 | 2003 |
Fundamental Metrics
Financial Performance| Metric | LVLU | DYAI |
|---|---|---|
| Price | $11.60 | $0.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 51.3K | ★ 175.5K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $282,284,000.00 | $3,090,345.00 |
| Revenue This Year | $5.66 | $122.79 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.26 | $0.48 |
| 52 Week High | $32.32 | $1.60 |
Technical Indicators
Market Signals| Indicator | LVLU | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | 25.78 |
| Support Level | $7.60 | N/A |
| Resistance Level | $11.99 | $0.90 |
| Average True Range (ATR) | 1.66 | 0.06 |
| MACD | -0.35 | -0.01 |
| Stochastic Oscillator | 14.50 | 10.78 |
Price Performance
Historical ComparisonAbout LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates the majority of its revenue from customers based in the United States.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.